A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram

BACKGROUND: Glioblastoma (GBM) is the most common primary malignant brain tumor in adulthood. Despite multimodality treatments, including maximal safe resection followed by irradiation and chemotherapy, the median overall survival times range from 14 to 16 months. However, a small subset of GBM pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurooncol Adv
Main Authors: Ferguson, Sherise D, Hodges, Tiffany R, Majd, Nazanin K, Alfaro-Munoz, Kristin, Al-Holou, Wajd N, Suki, Dima, de Groot, John F, Fuller, Gregory N, Xue, Lee, Li, Miao, Jacobs, Carmen, Rao, Ganesh, Colen, Rivka R, Xiu, Joanne, Verhaak, Roel, Spetzler, David, Khasraw, Mustafa, Sawaya, Raymond, Long, James P, Heimberger, Amy B
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780842/
https://ncbi.nlm.nih.gov/pubmed/33426529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa146
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados